Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation
Clinical trial NCT01882374 · WITHDRAWN
Trial details
- NCT number
- NCT01882374
- Sponsor
- Tarix Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2013-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.